NO931477D0 - Avbildning av infeksjoner - Google Patents

Avbildning av infeksjoner

Info

Publication number
NO931477D0
NO931477D0 NO931477A NO931477A NO931477D0 NO 931477 D0 NO931477 D0 NO 931477D0 NO 931477 A NO931477 A NO 931477A NO 931477 A NO931477 A NO 931477A NO 931477 D0 NO931477 D0 NO 931477D0
Authority
NO
Norway
Prior art keywords
pct
date
sec
infections
image
Prior art date
Application number
NO931477A
Other languages
English (en)
Other versions
NO310499B1 (no
NO931477L (no
Inventor
Kishor Khandubhai Solanki
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of NO931477L publication Critical patent/NO931477L/no
Publication of NO931477D0 publication Critical patent/NO931477D0/no
Publication of NO310499B1 publication Critical patent/NO310499B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19931477A 1991-08-23 1993-04-22 Radiomerket antibiotisk 4-kinolonforbindelse, dens anvendelse og sett og blandinger inneholdende det samme NO310499B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919118183A GB9118183D0 (en) 1991-08-23 1991-08-23 Imaging of infections
PCT/GB1992/001548 WO1993003772A1 (en) 1991-08-23 1992-08-21 Imaging of infections

Publications (3)

Publication Number Publication Date
NO931477L NO931477L (no) 1993-04-22
NO931477D0 true NO931477D0 (no) 1993-04-22
NO310499B1 NO310499B1 (no) 2001-07-16

Family

ID=10700409

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19931477A NO310499B1 (no) 1991-08-23 1993-04-22 Radiomerket antibiotisk 4-kinolonforbindelse, dens anvendelse og sett og blandinger inneholdende det samme

Country Status (14)

Country Link
US (1) US5425935A (no)
EP (1) EP0554434B1 (no)
JP (2) JP3650107B2 (no)
KR (1) KR100242177B1 (no)
AT (1) ATE206934T1 (no)
AU (1) AU665568B2 (no)
CA (1) CA2094494C (no)
DE (1) DE69232134T2 (no)
DK (1) DK0554434T3 (no)
ES (1) ES2161694T3 (no)
FI (1) FI119972B (no)
GB (2) GB9118183D0 (no)
NO (1) NO310499B1 (no)
WO (1) WO1993003772A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0692978A4 (en) * 1993-03-31 1998-05-06 Mallinckrodt Medical Inc RADIOPHARMACEUTICAL PREPARATIONS THAT DO NOT CONTAIN TIN REDUCER
US5804158A (en) * 1995-05-31 1998-09-08 Resolution Pharmaceuticals Inc. Sequestered imaging agents
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6017511A (en) * 1997-05-30 2000-01-25 Resolution Pharmaceuticals Inc. Glycopeptide-chelator conjugates
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
KR20020064057A (ko) * 2001-01-31 2002-08-07 최원식 세균감염 핵의학 영상진단 키트의 제조방법 및 그 키트준비물, 그 키트를 이용한 세균감염 진단방법
DE10139965B4 (de) * 2001-08-14 2005-12-29 Biotest Ag Gammasterilisierbares Kulturmedium zum Nachweis von Hefen und Pilzen
US20060110787A1 (en) * 2004-11-19 2006-05-25 The Board Trustees Of The University Of Arkansas Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection
KR100806368B1 (ko) * 2006-03-10 2008-02-27 최원식 결핵 핵의학 영상 조영제로서의 방사성 핵종-피라진아미드조성물 및 그 키트
RU2309677C1 (ru) * 2006-05-02 2007-11-10 Вера Дмитриевна Завадовская Способ дифференциальной диагностики неспецифических воспалительных процессов и злокачественных новообразований опорно-двигательного аппарата
EP2056709A4 (en) * 2006-08-11 2013-05-01 Univ New Jersey Med DOUBLE-SENSITIZER WITH LUMINESCENCE COMPOUNDS, CONJUGATES AND USE
CN101665520B (zh) * 2009-10-16 2011-12-07 北京师范大学 一种99TcmN(NFXDTC)2配合物及其制备方法和应用
US9221759B2 (en) 2010-01-13 2015-12-29 Rutgers, The State University Of New Jersey Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
RU2506954C1 (ru) * 2012-12-05 2014-02-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" СПОСОБ ПРИГОТОВЛЕНИЯ РЕАГЕНТА ДЛЯ ПОЛУЧЕНИЯ МЕЧЕНОГО ТЕХНЕЦИЕМ-99м НОРФЛОКСАЦИНА
DE102017218119A1 (de) 2017-10-11 2019-04-11 Christian-Albrechts-Universität Zu Kiel In der Umwelt abbaubare Chinolon-Antibiotika mit Hemiaminal-Struktureinheit

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873680A (en) * 1972-08-30 1975-03-25 Minnesota Mining & Mfg Mercaptan and thioketal complexes of technetium 99M for diagnostic scanning
FR2281134A1 (fr) * 1974-08-06 1976-03-05 Commissariat Energie Atomique Procede de marquage au 99m technetium
USRE31463E (en) * 1975-03-03 1983-12-13 Research Corporation Radiopharmaceutical chelates and method of external imaging
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
HU198709B (en) * 1987-04-08 1989-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
US5245026A (en) * 1987-09-24 1993-09-14 Abbott Laboratories Metal containing 8-hydroxyquinoline chelating agents
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
AU647772B2 (en) * 1989-12-29 1994-03-31 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats

Also Published As

Publication number Publication date
NO310499B1 (no) 2001-07-16
FI931822A0 (fi) 1993-04-22
NO931477L (no) 1993-04-22
ES2161694T3 (es) 2001-12-16
DK0554434T3 (da) 2001-11-12
WO1993003772A1 (en) 1993-03-04
GB2262937B (en) 1995-07-12
FI931822L (fi) 1993-04-22
KR930701965A (ko) 1993-09-08
EP0554434B1 (en) 2001-10-17
GB9217828D0 (en) 1992-10-07
CA2094494A1 (en) 1993-02-24
FI119972B (fi) 2009-05-29
AU665568B2 (en) 1996-01-11
AU2470192A (en) 1993-03-16
JP3650107B2 (ja) 2005-05-18
CA2094494C (en) 2005-07-12
KR100242177B1 (ko) 2000-03-02
JPH06505995A (ja) 1994-07-07
ATE206934T1 (de) 2001-11-15
DE69232134D1 (de) 2001-11-22
GB2262937A (en) 1993-07-07
US5425935A (en) 1995-06-20
JP2004132990A (ja) 2004-04-30
GB9118183D0 (en) 1991-10-09
EP0554434A1 (en) 1993-08-11
DE69232134T2 (de) 2002-03-21

Similar Documents

Publication Publication Date Title
NO931477L (no) Avbildning av infeksjoner
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
WO1991000048A3 (en) Transmission/emission registered image (teri) computed tomography scanners
FI935397A0 (fi) Foerfarande och anordning foer utloesning av en roentgenbildsensor
NO930088D0 (no) 4-alkylimidazolderivater
RU94046010A (ru) Комплексообразующие соединения и иммунореагенты направленного действия, применяемые в терапевтических целях, способ получения изображения, композиции, способ лечения
SE7907764L (sv) 3-osubstituerade 3-cefemforeningar
DE69613975D1 (de) Dialkyltiacumicine
NO914375L (no) 7-acyl-3-(substituerte carbamoyloxy)cefem-forbindelser ogfremgangsmaate for fremstilling av disse
NO924139L (no) Anordning for tilveiebringelse av en sammensatt digital fremstilling av en scene samt fremgangsmaate derved
FI101305B1 (fi) Radiofarmaseuttisena aineena käyttökelpoiset radiojodatut bentsodiatsepiini-johdannaiset ja niiden käyttö diagnostiikassa
ATE1551T1 (de) Cephemderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen.
ATE17576T1 (de) 4-phenyl-quinazolin-derivate wirksam auf das zentralnervensystem.
DE69118520D1 (de) Sechsbindige liganden für radiographische abbildungsagenzien
SE8007290L (sv) Tomografiavsokningsanordning
IT1266005B1 (it) Apparecchiatura per l'acquisizione di immagini, particolarmente per radiologia dentale
SE8701019D0 (sv) Makrolidforening
Fawwaz et al. Localization of gallium-67 in the normally functioning allografted kidney: concise communication
ES8203417A1 (es) Un procedimiento para la preparacion de un antibiotico ma- crolida
ES8304932A1 (es) Un procedimiento para la preparacion de derivados de cistina".
GR3019565T3 (en) Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates
Lusaka Parotitis with secondary syphilis
GR3015592T3 (en) Pharmaceuticals containing substituted cyclohex-2-en-1-yl-amine derivatives and their use in combatting diseases.
Ryan et al. Laboratory diagnosis of infectious diseases.
SE8801467L (sv) Sett och komposition for avlegsnande av radioaktiva cesiumisotoper i biologiska system

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees